ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМП10.25789/YMJ.2021.76.20ymj-604Research ArticleАКТУАЛЬНАЯ ТЕМАACTUAL TOPICПостковидный синдром хронической усталости и нарушения эмоциональной сферы у жителей г. ЯкутскаPost-COVID 19 syndrome of chronic fatigue and emotional disorders in residents of YakutskВарламоваМ. А.VarlamovaM. A.

Варламова Марина Алексеевна – н.с., врач невролог Клиники ЯНЦ КМП

Varlamova Marina Alekseevna – research associate, neurologist of the Clinic of YSC CMP

varlamova.m@yandex.ruДавыдоваТ. К.DavydovaT. K.

Давыдова Татьяна Кимовна – к.м.н., в.н.с.-руковод. лаб.

Davydova Tatyana Kimovna – Candidate of Medical Sciences, associate researcher, head of the lab.

ОлесоваЛ. Д.OlesovaL. D.

Олесова Любовь Дыгыновна – к.б.н., в.н.с.-руковод. лаб.

Olesova Lyubov Dygynovna –Candidate of Biological Sciences, associate researcher, head of the lab.

МакароваВ. А.MakarovaV. A.

Макарова Виктория Алексеевна – гл. врач

г. Якутск

Makarova Victoria Alekseevna – chief physician

Yakutsk

Якутский НЦ комплексных медицинских проблемРоссияYSC CMPRussian FederationКлиника «Дельта»РоссияDelta ClinicRussian Federation202104052025048689Copyright © Варламова М.А., Давыдова Т.К., Олесова Л.Д., Макарова В.А., 20252025Варламова М.А., Давыдова Т.К., Олесова Л.Д., Макарова В.А.Varlamova M.A., Davydova T.K., Olesova L.D., Makarova V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/604

Проведен анализ синдрома хронической усталости и уровня тревоги и депрессии у пациентов в возрасте от 20 до 72 лет, перенесших острую инфекцию COVID-19 от 3 до 12 мес. назад к моменту исследования. Женщины молодого и среднего возраста более подвержены вирусной пневмонии COVID-19 в тяжелой и критически тяжелой форме. Тяжелее перенесли COVID-19 по сравнению с женщинами мужчины в возрасте 32-51 и 61-70 лет. Тревожно-депрессивные расстройства и синдром хронической усталости могут развиться на любом сроке постковидного периода от 3 мес. до 12 мес.

The analysis of chronic fatigue syndrome and the level of anxiety and depression was conducted in 161 patients aged 20 to 72 years who had an acute infection with COVID-19 from 3 to 12 months ago. Young and middle-aged women are more susceptible to COVID-19 viral pneumonia in severe and critically severe form. Men are more severely affected by COVID-19 compared to women aged 32-51 and 61-70. Anxiety-depressive disorders and chronic fatigue syndrome can develop at any time in the post-ovarian period, from 3 months to 12 months.

COVID-19постковидный синдромтревожно-депрессивный синдромсиндром хронической усталостишкала HADSCOVID-19postcoid syndromeanxiety-depressive syndromechronic fatigue syndromeHADS scaleДанное исследование проведено в рамках инициативного проекта Якутского научного центра комплексных медицинских проблем «Комплексная оценка здоровья пациентов, перенесших новую короновирусную инфекцию (COVID-19)».This study was carried out as part of the initiative project of the Yakutsk Scientific Center for Complex Medical Problems "Comprehensive assessment of the health of patients who have undergone a new coronavirus infection (COVID-19)."ReferencesВозможные подходы к терапии астенических и когнитивных нарушений при постковидном синдроме / А. Н. Боголепова, Н. А. Осиновская, Е. А. Коваленко, Е. В. Махнович // Неврология, нейропсихиатрия, психосоматика. – 2021. – Т. 13. – № 4. – С. 88-93. – DOI: 10.14412/2074-2711-2021-4-88-93.Bogolepova AN, Osinovskaya NA, Kovalenko EA, Makhnovich EV. Possible approaches to the therapy of asthenic and cognitive disorders in postcoid syndrome. Nevrologiya, nejropsihiatriya, psihosomatika. 2021; 13 (4): 88-93. - DOI: 10.14412/2074-2711-2021-4-88-93.Постковидные неврологические синдромы / В.В. Белопасов, Е.Н. Журавлева, Н.П Нугманова [и др.]. - Клиническая практика. - 2021. - Т. 12. - №2. - C. 69-82. doi: 10.17816/clinpract71137.Belopasov VV, Zhuravleva EN, Nugmanova NP, et al. Postcovid neurological syndromes. Klinicheskaya practika. 2021; 12 (2): 69-82. doi: 10.17816/clinpract71137.Психоэмоциональные расстройства и нарушения сна у пациентов с COVID-19 / М. А. Самушия, С.М. Крыжановский, А.А. Рагимова [и др.]. // Журнал неврологии и психиатрии им. С.С. Корсакова. – 2021. – Т. 121. – №4. – вып. 2. – С. 49-54. DOI: 10.17116/jnevro202112104249Samushia MA, Kryzhanovsky SM, Ragimov AA, et al. Psychoemotional disorders and sleep disorders in patients with COVID-19. Jhurnal Nevrologii i psykhiatrii im. S.S. Korsakova. 2021; 121 (4) 2: 49-54. DOI: 10.17116/jnevro202112104249Путилина М.В. Астенические расстройства как проявление синдрома хронической усталости // Журнал неврологии и психиатрии им. С.С. Корсакова. – 2021. – Т. 121. - №8. – С. 125-130 DOI: 10.17116/jnevro2021121081125Putilina MV. Asthenic disorders as a manifestation of chronic fatigue syndrome. Jhurnal nevrologii and psickiatrii im. S.S. Korsakov. 2021; 121(8): 125-130. DOI: 10.17116/jnevro2021121081125Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact medRxiv preprint. doi: 10.1101/2020.12.24.20248802; this version posted April 5, 2021. Available from: https://www.medrxiv.org/content/10.1101/2020.12.24.20248802v3Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact medRxiv preprint. doi: 10.1101/2020.12.24.20248802; this version posted April 5, 2021. Available from: https://www.medrxiv.org/content/10.1101/2020.12.24.20248802v3Nekaeva ES, Bolshakova AE, Malysheva ES, et al. Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults Gender. Sovrem Tekhnologii Med. 2021; 13(4): 16-24. doi: 10.17691/stm2021.13.4.02.Nekaeva ES, Bolshakova AE, Malysheva ES, et al. Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults Gender. Sovrem Tekhnologii Med. 2021; 13(4): 16-24. doi: 10.17691/stm2021.13.4.02.Baig A, Khaleeq A, Ali U, et all. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution. Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosc. 2020 Apr 1; 11(7):995-8. doi: 10.1021/acschemneuro.0c00122Baig A, Khaleeq A, Ali U, et all. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution. Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosc. 2020 Apr 1; 11(7):995-8. doi: 10.1021/acschemneuro.0c00122Maltezou HC, Pavli A, Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021 May 12;9 (5):497. doi: 10.3390/vaccines9050497Maltezou HC, Pavli A, Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021 May 12;9 (5):497. doi: 10.3390/vaccines9050497Greenhalgh T, Knight M, A’Court M, et al. Management of post-acute COVID-19 in primary care. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026Greenhalgh T, Knight M, A’Court M, et al. Management of post-acute COVID-19 in primary care. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: Incidence, clinical spectrum, and challenges for primary healthcare professionals Arch Med Res. 2021 May 4. S0188-4409(21)00081-3. doi: 10.1016/j.arcmed.2021.03.010. Online ahead of print.Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: Incidence, clinical spectrum, and challenges for primary healthcare professionals Arch Med Res. 2021 May 4. S0188-4409(21)00081-3. doi: 10.1016/j.arcmed.2021.03.010. Online ahead of print.Goёrtz YMJ, van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020 Oct 26;6(4):00542-2020. doi: 10.1183/23120541.00542-2020. eCollection 2020 Oct.Goёrtz YMJ, van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020 Oct 26;6(4):00542-2020. doi: 10.1183/23120541.00542-2020. eCollection 2020 Oct.Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. Post-acute COVID-19: An overview and approach to classification. Open Forum Infect Dis. 2020 Oct 21;7(12):ofaa509. doi: 10.1093/ofid/ofaa509. eCollection 2020 Dec.Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. Post-acute COVID-19: An overview and approach to classification. Open Forum Infect Dis. 2020 Oct 21;7(12):ofaa509. doi: 10.1093/ofid/ofaa509. eCollection 2020 Dec.Halpin SJ, McIvor C, Whyatt EG, et al. Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93:1013-22. doi: 10.1002/jmv.26368Halpin SJ, McIvor C, Whyatt EG, et al. Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93:1013-22. doi: 10.1002/jmv.26368Rhie SJ, Jung EY, Shim I. The role of neuroinflammation on pathogenesis of affective disorders. J Exerc Rehabil. 2020;16:2-9. doi: 10.12965/jer.2040016.008. eCollection 2020 Feb.Rhie SJ, Jung EY, Shim I. The role of neuroinflammation on pathogenesis of affective disorders. J Exerc Rehabil. 2020;16:2-9. doi: 10.12965/jer.2040016.008. eCollection 2020 Feb.Ritchie K, Chan D, Watermeyer T. The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun. 2020 May 28;2(2):fcaa069. doi: 10.1093/brain-comms/fcaa069. eCollection 2020.Ritchie K, Chan D, Watermeyer T. The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun. 2020 May 28;2(2):fcaa069. doi: 10.1093/brain-comms/fcaa069. eCollection 2020.

The authors declare that there are no conflicts of interest present.